MedTrace Logo

Gut Microbiota in ITP

NCT05118126 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2022-01-12

No results posted yet for this study

Summary

Prospective, observational study to explore the significance of gut microbiome in the diagnosis of ITP, and to identify the predictive value of baseline gut microbiome for GC resistance/relapse.

Conditions

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Xiao-Hui Zhang, Dr. · Peking University People's Hospital, Peking University Insititute of Hematology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05118126 on ClinicalTrials.gov